Artemisinin derivatives as potential drug candidates against Mycobacterium tuberculosis: insights from molecular docking, MD simulations, PCA, MM/GBSA and ADMET analysis

References

• Kim PS, Swaminathan S. Ending TB: the world’s oldest pandemic. J Int AIDS Soc. 2021;24(3):10–11. doi:10.1002/jia2.25698
   Web of Science ®Google Scholar
• World Health Organization. World Health Organization Global Tuberculosis Report 2022. URL:https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022.
   Google Scholar
• World Health Organization. World Health Organization Global Tuberculosis Report 2021. https://www.who.int/publications/i/item/9789240037021.
   Google Scholar
• Malmborg R, Mann G, Squire SB. A systematic assessment of the concept and practice of public-private mix for tuberculosis care and control. Int J Equity Health. 2011;10:1–9. doi:10.1186/1475-9276-10-49
   PubMed Web of Science ®Google Scholar
• Davies PDO. The role of DOTS in tuberculosis treatment and control. Am J Respir Med. 2003;2:203–209. doi:10.1007/BF03256649
   PubMedGoogle Scholar
• Bocchino M, Matarese A, Sanduzzi A. Current treatment options for latent tuberculosis infection. J Rheumatol Suppl. 2014;91(0):71–77. doi:10.3899/jrheum.140105
   PubMedGoogle Scholar
• Cinu TA, Sidhartha SK, Indira B, et al. Design, synthesis and evaluation of antitubercular activity of Triclosan analogues. Arab J Chem. 2019;12(8):3316–3323. doi:10.1016/j.arabjc.2015.09.003
   Web of Science ®Google Scholar
• Machova I, Snášel J, Dostál J, et al. Structural and functional studies of phosphoenolpyruvate carboxykinase from Mycobacterium tuberculosis. PLoS One. 2015;10(3):1–21. doi:10.1371/journal.pone.0120682
   Web of Science ®Google Scholar
• Marrero J, Rhee KY, Schnappinger D, et al. Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc Natl Acad Sci. 2010;107(21):9819–9824. doi:10.1073/pnas.1000715107
   PubMed Web of Science ®Google Scholar
• Zhou B, Yue JM. Natural products are the treasure pool for antimalarial agents. Natl Sci Rev. 2022;9(11):nwac112. doi:10.1093/nsr/nwac112
   PubMed Web of Science ®Google Scholar
• Ma N, Zhang Z, Liao F, et al. The birth of artemisinin. Pharmacol Ther. 2020;216:107658. doi:10.1016/j.pharmthera.2020.107658
   PubMed Web of Science ®Google Scholar
• Peter S, Jama S, Alven S, et al. Artemisinin and derivatives-based hybrid compounds: promising therapeutics for the treatment of cancer and Malaria. Molecules. 2021;26(24):7521. doi:10.3390/molecules26247521
   PubMed Web of Science ®Google Scholar
• Patel YS, Mistry N, Mehra S. Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin. Tuberculosis. 2019;115:146–153. doi:10.1016/j.tube.2019.03.004
   PubMed Web of Science ®Google Scholar
• Choi WH. Novel pharmacological activity of artesunate and artemisinin: their potential as anti-tubercular agents. J Clin Med. 2017;6(3):30. doi:10.3390/jcm6030030
   PubMed Web of Science ®Google Scholar
• Ali I, Rasheed MA, Cavalu S, et al. Identification of natural lead compounds against hemagglutinin-esterase surface glycoprotein in human coronaviruses investigated via MD simulation, principal component analysis, cross-correlation, H-bond plot and MMGBSA. Biomedicines. 2023;11(3):793. doi:10.3390/biomedicines11030793
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang X, Pearce R, et al. A new protocol for atomic-level protein structure modeling and refinement using low-to-medium resolution Cryo-EM density maps. J Mol Biol. 2020;432(19):5365–5377. doi:10.1016/j.jmb.2020.07.027
   PubMed Web of Science ®Google Scholar
• Halgren TA. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J Comput Chem. 1996;17(5-6):520–552. doi:10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W
   Web of Science ®Google Scholar
• O'Boyle NM, Banck M, James CA, et al. Open babel: an open chemical toolbox. J Cheminform. 2011;3(33):1–14. doi:10.1186/1758-2946-3-33
   PubMedGoogle Scholar
• Chauhan S, Srivastava M, Singh J. DocVSP (Docking-based virtual screening Perl-script) for automating and integrating AutoDock and SBDD. 2021;287–291. doi:10.52458/978-93-91842-08-6-28
   Google Scholar
• Zhang S, Kumar K, Jiang X, et al. DOVIS: an implementation for high-throughput virtual screening using AutoDock. BMC Bioinformatics. 2008;9:1–4. doi:10.1186/1471-2105-9-126
   PubMed Web of Science ®Google Scholar
• Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Chem Biol: Methods Protoc. 2015: 1263:243–250. doi:10.1007/978-1-4939-2269-7_19
   Google Scholar
• Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998;19(14):1639–1662. doi:10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Web of Science ®Google Scholar
• Yuan S, Chan HS, Hu Z. Using PyMOL as a platform for computational drug design. WIREs Comput Mol Sci. 2017;7(2):e1298. doi:10.1002/wcms.1298
   Google Scholar
• Accelrys SI. Discovery studio modeling environment. San Diego (CA): Dassault Systèmes BIOVIA; 2017.
   Google Scholar
• Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng, Design Sel. 1995;8(2):127–134. doi:10.1093/protein/8.2.127
   Web of Science ®Google Scholar
• Pires DE, Kaminskas LM, Ascher DB. Prediction and optimization of pharmacokinetic and toxicity properties of the ligand. Comput Drug Discov Design. 2018;1762:271–284. doi:10.1007/978-1-4939-7756-7_14
   Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717. doi:10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337–341. doi:10.1016/j.ddtec.2004.11.007
   PubMedGoogle Scholar
• Ogu CC, Maxa JL. Drug interactions due to cytochrome P450. In Baylor University Medical Center Proceedings. Taylor & Francis. 2000;13(4):421–423. doi:10.1080/08998280.2000.11927719
   Google Scholar
• Drwal MN, Banerjee P, Dunkel M, et al. ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res. 2014;42(W1):W53–W58. doi:10.1093/nar/gku401
   PubMed Web of Science ®Google Scholar
• Boldon L, Laliberte F, Liu L. Review of the fundamental theories behind small angle X-ray scattering, molecular dynamics simulations, and relevant integrated application. Nano Rev. 2015;6(1):25661. doi:10.3402/nano.v6.25661
   PubMedGoogle Scholar
• Cuya T, Goncalves AD, da Silva JA, et al. The role of the oximes HI-6 and HS-6 inside human acetylcholinesterase inhibited with nerve agents: a computational study. J Biomol Struct Dyn. 2018 Oct 3;36(13):3444–3452. doi:10.1080/07391102.2017.1389307
   PubMed Web of Science ®Google Scholar
• Van Der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701–1718. doi:10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Huang J, MacKerell AD, Jr. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem. 2013;34(25):2135-2145. doi:10.1002/jcc.23354
   PubMed Web of Science ®Google Scholar
• Zoete V, Cuendet MA, Grosdidier A, et al. SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem. 2011;32(11):2359–2368. doi:10.1002/jcc.21816
   PubMed Web of Science ®Google Scholar
• Lamichhane TR, Ghimire MP. Evaluation of SARS-CoV-2 main protease and inhibitor interactions using dihedral angle distributions and radial distribution function. Heliyon. 2021;7(10):1–9. doi:10.1016/j.heliyon.2021.e08220.
   Web of Science ®Google Scholar
• Gonçalves MA, Santos LS, Prata DM, et al. Optimal wavelet signal compression as an efficient alternative to investigate molecular dynamics simulations: application to thermal and solvent effects of MRI probes. Theor Chem Acc. 2017;136:1–13. doi:10.1007/s00214-016-2037-z
   Web of Science ®Google Scholar
• Gonçalves MA, Gonçalves AS, Franca TC, et al. Improved protocol for the selection of structures from molecular dynamics of organic systems in solution: the value of investigating different wavelet families. J Chem Theory Comput. 2022;18(10):5810–5818. doi:10.1021/acs.jctc.2c00593
   PubMed Web of Science ®Google Scholar
• Pandey B, Grover A, Sharma P. Molecular dynamics simulations revealed structural differences among WRKY domain-DNA interaction in barley (Hordeum vulgare). BMC Genom. 2018;19(1):1–16. doi:10.1186/s12864-017-4368-0
   PubMedGoogle Scholar
• Amadei A, Linssen AB, Berendsen HJ. Essential dynamics of proteins. Proteins: Struct, Funct Bioinform. 1993;17(4):412–425. doi:10.1002/prot.340170408
   PubMed Web of Science ®Google Scholar
• Shukla R, Singh TR. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer’s disease. J Biomol Struct Dyn. 2020;38(1):248–262. doi:10.1080/07391102.2019.1571947
   PubMed Web of Science ®Google Scholar
• Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10(5):449–461. doi:10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Kumar P, Choonara YE, Pillay V. In silico affinity profiling of neuroactive polyphenols for post-traumatic calpain inactivation: a molecular docking and atomistic simulation sensitivity analysis. Molecules. 2015;20(1):135–168. doi:10.3390/molecules20010135
   Web of Science ®Google Scholar
• Srinivasan J, Cheatham TE, Cieplak P, et al. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate−DNA helices. J Am Chem Soc. 1998;120(37):9401–9409. doi:10.1021/ja981844+
   Web of Science ®Google Scholar
• Ibrahim MA, Abdeljawaad KA, Roshdy E, et al. In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents. Sci Rep. 2023;13(1):1–16. doi:10.1038/s41598-023-28226-7
   PubMed Web of Science ®Google Scholar
• Gilson MK, Honig B. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins: Struct, Funct Bioinform. 1988;4(1):7–18. doi:10.1002/prot.340040104
   PubMed Web of Science ®Google Scholar
• Wang J, Hou T, Xu X. Recent advances in free energy calculations with a combination of molecular mechanics and continuum models. Curr Comput-Aided Drug Des. 2006;2(3):287–306. doi:10.2174/157340906778226454
   Web of Science ®Google Scholar
• Kumari R, Kumar R. Open source drug discovery consortium, Lynn A. g_mmpbsa – a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 2014;54(7):1951–1962. doi:10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Motamen S, Quinn RJ. Analysis of approaches to anti-tuberculosis compounds. ACS Omega. 2020;5(44):28529–28540. doi:10.1021/acsomega.0c03177
   PubMed Web of Science ®Google Scholar
• Pitaloka DAE, Ramadhan DSF, Arfan, et al. Docking-based virtual screening and molecular dynamics simulations of quercetin analogs as enoyl-acyl carrier protein reductase (InhA) inhibitors of Mycobacterium tuberculosis. Sci Pharm. 2021;89(2):20. doi:10.3390/scipharm89020020
   Web of Science ®Google Scholar
• Al-Khodairy FM, Khan MK, Kunhi M, et al. In Silico prediction of mechanism of Erysolin-induced apoptosis in human breast cancer cell lines. Am J Bioinform Res. 2013;3(3):62–71. doi:10.5923/j.bioinformatics.20130303.03
   Google Scholar
• Kuzmanic A, Zagrovic B. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophys J. 2010;98(5):861–871. doi:10.1016/j.bpj.2009.11.011
   PubMed Web of Science ®Google Scholar
• Sharma A, Vora J, Patel D, et al. Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches. J Biomol Struct Dyn. 2022;40(7):3296–3311. doi:10.1080/07391102.2020.1846624
   PubMed Web of Science ®Google Scholar
• Saba A, Muhammad S, Khera RA, et al. Identification of halogen-based derivatives as potent inhibitors of estrogen receptor alpha of breast cancer: an in-silico investigation. J Comput Biophys Chem. 2022 Mar 4;21(02):181–205. doi:10.1142/S2737416522500090
   Google Scholar
• Kumar KM, Anbarasu A, Ramaiah S. Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins. Mol Biosyst. 2014;10(4):891–900. doi:10.1039/c3mb70537d
   PubMedGoogle Scholar
• Khan RJ, Jha RK, Amera GM, et al. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. J Biomol Struct Dyn. 2021;39(8):2679–2692. doi:10.1080/07391102.2020.1753577
   PubMed Web of Science ®Google Scholar
• Saha RP, Bahadur RP, Chakrabarti P. Interresidue contacts in proteins and protein− protein interfaces and their use in characterizing the homodimeric interface. J Proteome Res. 2005;4(5):1600–1609. doi:10.1021/pr050118k
   PubMed Web of Science ®Google Scholar
• Hubbard RE, Haider MK. Hydrogen bonds in proteins: role and strength. eLS. 2010. doi:10.1002/9780470015902.a0003011.pub2
   Google Scholar
• Siddiqui S, Ameen F, Kausar T, et al. Biophysical insight into the binding mechanism of doxofylline to bovine serum albumin: an in vitro and in silico approach. Spectrochimica Acta A Mol Biomol Spectrosc. 2021;249:119296. doi:10.1016/j.saa.2020.119296
   PubMed Web of Science ®Google Scholar